IRCT20201227049847N1RecruitingPhase 3
Comparison of efficacy and safety of Diphereline 11.25 mg, Microreline 11.25 mg, and Microreline 3.75mg in premenopausal breast cancer patients
Homa Pharmed Company0 sites210 target enrollmentStarted: TBDLast updated:
Conditions
Trial Snapshot
- Phase
- Phase 3
- Status
- Recruiting
- Sponsor
- Enrollment
- 210
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 18 years to no limit (—)
- Sex
- Female
Inclusion Criteria
- •Age over 18 years
- •Positive estrogen and progesterone receptor
- •Premenopausal patients
- •Perimenopausal patients, if they have the same estradiol levels as premenopausal women.
Exclusion Criteria
- •Existence of metastasis
- •History of hysterectomy and oophorectomy
Investigators
Similar Trials
Completed
Phase 2
Comparison of efficacy of Diphereline ( IPSEN, France) and Variopeptyl (Varian pharmed, IRAN) in treatment of girls with idiopathic central precocious puberty (CPP)IRCT20170225032759N1Private36
Active, not recruiting
Not Applicable
Comparison of efficacy and safety of different regimens of sublingual immunotherapy for Ragweed.EUCTR2011-001682-41-ITAZIENDA OSPEDALIERA L. SACCO (A.O. DI RILIEVO NAZIONALE)45
Recruiting
Not Applicable
Comparisons of different filling materials in Non carious cervical Lesion .CTRI/2021/08/035494Dr Tanu300
Not yet recruiting
Not Applicable
Clinical investigation of the effectiveness of different mouth rinses in Covid-19-PatientsCOVID-19DRKS00023725niversität Witten/Herdecke Fakultät für Gesundheit (Department für Zahn-, Mund- und Kieferheilkunde)Lehrstuhl für Zahnerhaltung und Präventive Zahnmedizin60
Completed
Not Applicable
The clinical study of the safety and efficacy of docetaxel combined with ribavirin in docetaxel resistant castration resistant prostate cancerProstate cancerJPRN-UMIN000015130Keio University School of Medicine, Department of Urology20